Skip to main content

Advertisement

Log in

Epilepsy and episodic ataxia type 2: family study and review of the literature

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Episodic ataxia type 2 (EA2) is a hereditary disorder characterized by paroxysmal attacks of ataxia, vertigo and nausea, due to mutations in the CACNA1A gene, which encodes for α1 subunit of the P/Q-type voltage-gated Ca2+ channel (CaV2.1). Other manifestations may be associated to CACNA1A mutations, such as migraine and epilepsy. The correlation between episodic ataxia and epilepsy is often underestimated and misdiagnosed. Clinical presentation of EA2 varies among patients and within the same family, and the same genetic mutation can lead to different clinical phenotypes. We herewith describe an Italian family presenting with typical EA2 and, in two of the family members (patients II.3 and III.1), epileptic seizures. The sequencing revealed a heterozygous deletion of 6 nucleotides in exon 28 of CACNA1A gene, present in all affected patients. Evidence suggests that mutations of CACNA1A, conferring a loss/reduction of CaV2.1 function, lead to an increase of thalamocortical excitation that contributes to epileptiform discharges. Our description highlights intra-family variability of EA2 phenotype and suggests that mutations in the CACNA1A gene should be suspected in individuals with focal or generalized epilepsy, associated with a family history of episodic ataxia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Neurology 62(1):17–22. https://doi.org/10.1212/01.wnl.0000101675.61074.50

    Article  CAS  PubMed  Google Scholar 

  2. Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521–555. https://doi.org/10.1146/annurev.cellbio.16.1.52

    Article  CAS  PubMed  Google Scholar 

  3. Mantuano E, Romano S, Veneziano L, Gellera C, Castellotti B, Caimi S et al (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci 291(1–2):30–36. https://doi.org/10.1016/j.jns.2010.01.010

    Article  CAS  PubMed  Google Scholar 

  4. Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaben J et al (2014) Consensus paper: management of degenerative cerebellar disorders. Cerebellum 13(2):248–268. https://doi.org/10.1007/s12311-013-0531-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T et al (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77(3):269–275. https://doi.org/10.1212/WNL.0b013e318225ab07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Guterman EL, Yurgionas B, Nelson AB (2016) Pearls & Oy-sters: episodic ataxia type 2: case report and review of the literature. Neurology 86:e239–e241. https://doi.org/10.1212/WNL.0000000000002743

    Article  PubMed  PubMed Central  Google Scholar 

  7. den Dunnen JT, Dalgleish R, Maglot DR, Hart RK, Greenblatt MS, McGowan-Giordan J et al (2016) HGVS Recommendations for the description of sequence variants: 2016 update. Hum Mutat 37(6):564–569. https://doi.org/10.1002/humu.22981 (Epub 2016 Mar 25)

    Article  CAS  Google Scholar 

  8. Baloh RW, Yue Q, Furman JM, Nelson SF (1997) Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41(1):8–16. https://doi.org/10.1002/ana.410410105

    Article  CAS  PubMed  Google Scholar 

  9. Rajakulendran S, Graves TD, Labrum RW, Kotzadimitriou D, Eunson L, Davis MB et al (2010) Genetic and functional characterization of the P/Q calcium channel in episodic ataxia with epilepsy. J Physiol 588(Pt 11):1905–1913. https://doi.org/10.1113/jphysiol.2009.186437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R et al (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127(Pt 12):2682–2692. https://doi.org/10.1093/brain/awh301

    Article  PubMed  Google Scholar 

  11. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi V, Kullmann D, Hanna MG (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358(9284):801–807. https://doi.org/10.1016/S0140-6736(01)05971-2

    Article  CAS  PubMed  Google Scholar 

  12. Jung J, Testard H, Tournier-Lasserve E, Riant F, Vallet AE, Berroir S, Broussolle E (2010) Phenotypic variability of episodic ataxia type 2 mutations: a family study. Eur Neurol 64:114–116. https://doi.org/10.1159/000315145

    Article  CAS  PubMed  Google Scholar 

  13. Damaj L, Lupien-Meilleur A, Lortie A, Riou E, Ospina LH, Gagnon L et al (2015) CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet 23(11):1505–1512. https://doi.org/10.1038/ejhg.2015.21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Holtmann M, Opp J, Tokarzewski M, Korn-Merker E (2002) Human epilepsy, episodic ataxia type 2, and migraine. Lancet 359(9301):170–171. https://doi.org/10.1016/S0140-6736(02)07355-5

    Article  CAS  PubMed  Google Scholar 

  15. Angelini C, Van Gils J, Bigourdan A, Jouk PS, Lacombe D, Menegon P et al (2019) Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. Eur J Med Genet 62(6):103530. https://doi.org/10.1016/j.ejmg.2018.08.011

    Article  PubMed  Google Scholar 

  16. Perucca E (1997) A pharmacological and clinical review on Topiramate, a new antiepileptic drug. Pharmacol Res 35(4):241–256. https://doi.org/10.1006/phrs.1997.0124

    Article  CAS  PubMed  Google Scholar 

  17. Matsushita K, Wakamori M, Rhyu IJ, Arii T, Oda S, Mori Y, Imoto K (2002) Bidirectional alterations in cerebellar synaptic transmission of tottering and rolling Ca2+ channel mutant mice. J Neurosci 22(11):4388–4398. https://doi.org/10.1523/JNEUROSCI.22-11-31404388.2002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Talley EM, Solòrzano G, Depaulis A, Perez-Reyes E, Bayliss DA (2000) Low-voltage activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 75(1):159–165. https://doi.org/10.1016/s0169-328x(99)00307-1

    Article  CAS  PubMed  Google Scholar 

  19. Llinàs RR, Choi S, Urbano FJ, Shin HS (2007) Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice. Proc Natl Acad Sci USA 104(45):17819–17824. https://doi.org/10.1073/pnas.0707945104

    Article  PubMed  PubMed Central  Google Scholar 

  20. Yi Z, Mori M, Burgess DL, Noebels JL (2002) Mutations in high voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 22(15):6362–6371. https://doi.org/10.1523/JNEUROSCI.22-15-06362.2002

    Article  Google Scholar 

  21. Rossignol E, Kruglikov I, van den Maagdenberg AMJM, Rudy B, Fishell G (2013) Cav2.1 ablation in cortical interneurons selectively impairs fast-spiking basket cells and causes generalized seizures. Ann Neurol 74(2):209–222. https://doi.org/10.1002/ana.23913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Vigues S, Gastaldi M, Chabret C, Massacrier A, Cau P, Valmier J (1999) Regulation of calcium channel alpha(1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy. Neurobiol Dis 6(4):288–301. https://doi.org/10.1006/nbdi.1999.0248

    Article  CAS  PubMed  Google Scholar 

  23. Das A, Wallace GC, Holmes C, McDowell ML, Smith JA, Marshall JD et al (2012) Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocytes activation, inflammation, and altered expression of channels and receptors. Neuroscience 220:237–246. https://doi.org/10.1016/j.neuroscience.2012.06.002

    Article  CAS  PubMed  Google Scholar 

  24. Lv N, Qu J, Long H, Zhou L, Cao Y, Long L et al (2015) Association study between polymorphisms in the CACNA1A, CACNA1C and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population. Seizure 30:64–69. https://doi.org/10.1016/j.seizure.2015.05.013

    Article  PubMed  Google Scholar 

  25. Song I, Kim D, Choi S, Sun M, Kim Y, Shin HS (2004) Role of the alpha1GT-type calcium channel in spontaneous absence seizures in mutant mice. J Neurosci 24(22):5249–5257. https://doi.org/10.1523/JNEUROSCI.5546-03.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rajakulendran S, Hanna MG (2016) The role of calcium channels in epilepsy. Cold Spring Harb Perspect Med 6(1):a022723. https://doi.org/10.1101/cshperspect.a022723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mantuano E, Veneziano L, Spadaro M, Giunti P, Guida S, Leggio MG et al (2004) Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Ca(v)2.1 causing episodic ataxia 2. J Med Genet 41(6):e82. https://doi.org/10.1136/jmg.2003.015396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Indelicato E, Unterberger I, Nachbauer W, Eigentler A, Amprosi M, Zeiner F et al (2021) The electrophysiological footprint of CACNA1A disorders. J Neurol. https://doi.org/10.1007/s00415-021-10415-x

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Data access, responsibility, and analysis: all the authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. We would like to thank the family for participating in this study.

Funding

No funding sources.

Author information

Authors and Affiliations

Authors

Contributions

LV: design and conceptualized study; acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content; study supervision. GP: design and conceptualized study; acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content; study supervision. AN: acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content. IL: acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content. EB: acquisition of data; interpreted the data; revised the manuscript for intellectual content. MV, FC and GLG: revised the manuscript for intellectual content; study supervision. All the authors approved the submitted version.

Corresponding author

Correspondence to Lorenzo Verriello.

Ethics declarations

Conflicts of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethical approval

The study was performed in accordance with the Declaration of Helsinki.

Informed consent

Informed consent was obtained.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verriello, L., Pauletto, G., Nilo, A. et al. Epilepsy and episodic ataxia type 2: family study and review of the literature. J Neurol 268, 4296–4302 (2021). https://doi.org/10.1007/s00415-021-10555-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10555-0

Keywords

Navigation